Skip to main content

Animations

MJFF Publications

7271 - 7280 of 8808 Results
Title
Year
  • Year
  • 2019
  • 2025
  • 2016
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2011
  • 2017
  • Summary Details
    RESTRICTED
    Title: Reply to letter to the editor “Adaptive DBS in Parkinson's disease: Headlines, perspectives and challenges”
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.brs.2019.06.014
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Sex‐ and region‐dependent neuroinflammation in Alzheimer's disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.14603
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Synthesis and characterization of a series of chiral alkoxymethyl morpholine analogs as dopamine receptor 4 (D4R) antagonists
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.03.102
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Multimodal oculomotor assessment reveals prodromal markers of Parkinson’s disease in non-manifesting LRRK2 G2019S mutation carriers
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-024-00840-w
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Mapping the human brain proteome: opportunities, challenges, and clinical potential
    Journal Name: Expert Review of Proteomics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/14789450.2024.2313073
    Citation Count: 3
  • Summary Details
    OPEN
    Title: USP14 inhibition enhances Parkin-independent mitophagy in iNeurons
    Journal Name: Pharmacological Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.phrs.2024.107484
    Citation Count: 2
  • Summary Details
    OPEN
    Title: An adapted protocol to derive microglia from stem cells and its application in the study of CSF1R-related disorders
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-024-00723-x
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Pathologic RFC1 repeat expansions do not contribute to the development of inflammatory neuropathies
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcae163
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: Four cases
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2011.06.003
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patients
    Journal Name: Toxicology Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.toxrep.2017.03.005
    Citation Count: 28
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.